Editas Medicine, Inc. SEC filings EDIT

Editas Medicine, Inc. has 727 filings in SEC EDGAR's recent list, going back to Aug 18, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Apr 28, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 28, 2026 Apr 28, 2026
10-K Annual report Mar 9, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 15, 2025 Apr 15, 2025
10-K Annual report Mar 5, 2025 Dec 31, 2024
10-K Annual report Feb 28, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 18, 2023 Dec 31, 2022
10-K Annual report Feb 22, 2023 Dec 31, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
10-K Annual report Feb 26, 2021 Dec 31, 2020
10-K Annual report Feb 26, 2020 Dec 31, 2019
10-K Annual report Mar 1, 2019 Dec 31, 2018
10-K Annual report Mar 8, 2018 Dec 31, 2017
10-K Annual report Mar 3, 2017 Dec 31, 2016
10-K Annual report Mar 30, 2016 Dec 31, 2015

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
EDIT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1650664

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.